VIVS
VivoSim Labs, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
VivoSim Labs (VIVS) Stock: Buy, Sell, or Hold?
$0.29
+0.17 (+142.92%)
▲
5d:
+111.39%
30d:
+64.69%
90d:
+1.92%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 12, 2026
Updated Nov 19, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (6%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$0.12 – $0.19
Position: EXTENDED
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.12 / $0.18
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: VIVS is 53.4% above its trading range ($0.19). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When VIVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VIVS is currently trading at $0.29, which is considered extended relative to its 30-day fair value range of $0.12 to $0.19.
Technical Outlook: Technically, VIVS is in a strong downtrend. The price is approaching resistance at $0.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 142.9% recently.
Market Sentiment: VIVS scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VIVS is in a strong downtrend. The price is approaching resistance at $0.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 142.9% recently.
Market Sentiment: VIVS scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.12 -
$0.19
Company Quality Score
36/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
5.9%
Trading Range & Key Levels
30-Day Trading Range
$0.12 -
$0.19
Current vs Trading Range
EXTENDED
Support Level
$0.12
Resistance Level
$0.18
Current Trend
Strong Downtrend
Technical data as of
Nov 18, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
73d (50% conf)
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+53.4% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: Strong upward momentum (+142.9%)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Revenue Growth (YoY)
-51.4%
Share VIVS Analysis
Share this live VIVS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VIVS)
Neutral
18 Retail Mentions
Retail Stream Volume
18 msgs
24h retail stream
Last Tracked
Nov 20, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is flooded with bullish sentiment towards $VIVS, with traders predicting price targets of $1 and beyond. The latest Yahoo Finance news reports VivoSim Labs securing a seven-figure pharmaceutical testing agreement, leading to increased revenue growth expectations for Fiscal 2027.
Key Retail Themes:
Bullish sentiment around $VIVS
Company's growth prospects
Aggregated from r/wallstreetbets, r/stocks & retail trader streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 20, 2026 5:04 AM ET
Data refreshes hourly during market hours. Next update: 6:04 AM
Data refreshes hourly during market hours. Next update: 6:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 50 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 49 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$106 | 57 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 40 SELL |
|
EPRX
Eupraxia Pharmaceuticals… |
STRONG BUY
13 analysts |
$17 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VIVS Research Pages
VIVS Technical Chart
VIVS Price Prediction
VIVS Intrinsic Value DCF
VIVS Earnings Date
VIVS Investment Advisor
VIVS Fair Price Analyzer
VIVS Target Price Playground
VIVS 5-Day Options Simulator
VIVS LEAP Simulator
VIVS Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
VIVS Competitors
Part B: Tradestie Flagship Market Scanners